Guarding Against Pertussis. The Efficacy and Advantages of the TdaP Vaccine
-
- Taschenbuch
- eBook ausgewählt
-
Form:Einzelkauf Download
-
Sprache:Englisch
15,99 €
inkl. gesetzl. MwSt.Beschreibung
Produktdetails
Format
Kopierschutz
Nein
Family Sharing
Nein
Text-to-Speech
Nein
Erscheinungsdatum
18.07.2023
Verlag
GRINSeitenzahl
38 (Printausgabe)
Dateigröße
1579 KB
Sprache
Englisch
EAN
9783346908582
Scientific Study from the year 2023 in the subject Medicine - Biomedical Engineering, grade: 3, , language: English, abstract: This paper aims to elucidate the importance of TdaP vaccines in the prevention of pertussis, highlight the increased risk of this disease in adults, and underscore the benefits of using acellular vaccines over whole-cell vaccines.
This text underscores the escalating threat of Pertussis (whooping cough) in adults and its lethal repercussions on infants with lesser immunity. This has led to innovations in vaccine development, particularly the emergence of acellular vaccines like the TdaP vaccine that effectively combats Tetanus, Diphtheria, and Pertussis. This vaccine offers the advantage of fewer side effects compared to whole-cell vaccines and contains purified antigenic components of Bordetella pertussis obtained through various purification techniques.
The increased risk of pertussis in adults have become an important public-health issue. This contagious disease spreads to infants who have lesser immunity resulting in their death. Increased death rate caused the inventions of vaccinations to prevent this disease. Concerns regarding the safety of whole-cell vaccines used for pertussis treatment lead to the development of acellular pertussis vaccines like TdaP vaccines. This combination vaccine is 71-85% effective in the treatment of adults suffering from diseases tetanus, diphtheria and pertussis. These vaccines have limited side effects when compared to whole-cell vaccines as they contain purified antigenic components of Bordet Ella pertussis (Pertussis toxin, Filamentous hemagglutinin and Pertactin) that are obtained by the purification techniques Tangential flow filtration, Column Chromatography and Dialysis. These components are then formulated for purified vaccine production.
This text underscores the escalating threat of Pertussis (whooping cough) in adults and its lethal repercussions on infants with lesser immunity. This has led to innovations in vaccine development, particularly the emergence of acellular vaccines like the TdaP vaccine that effectively combats Tetanus, Diphtheria, and Pertussis. This vaccine offers the advantage of fewer side effects compared to whole-cell vaccines and contains purified antigenic components of Bordetella pertussis obtained through various purification techniques.
The increased risk of pertussis in adults have become an important public-health issue. This contagious disease spreads to infants who have lesser immunity resulting in their death. Increased death rate caused the inventions of vaccinations to prevent this disease. Concerns regarding the safety of whole-cell vaccines used for pertussis treatment lead to the development of acellular pertussis vaccines like TdaP vaccines. This combination vaccine is 71-85% effective in the treatment of adults suffering from diseases tetanus, diphtheria and pertussis. These vaccines have limited side effects when compared to whole-cell vaccines as they contain purified antigenic components of Bordet Ella pertussis (Pertussis toxin, Filamentous hemagglutinin and Pertactin) that are obtained by the purification techniques Tangential flow filtration, Column Chromatography and Dialysis. These components are then formulated for purified vaccine production.
Noch keine Bewertungen vorhanden
Verfassen Sie die erste Bewertung zu diesem Artikel
Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.
Kurze Frage zu unserer Seite
Vielen Dank für Ihr Feedback
Wir nutzen Ihr Feedback, um unsere Produktseiten zu verbessern. Bitte haben Sie Verständnis, dass wir Ihnen keine Rückmeldung geben können. Falls Sie Kontakt mit uns aufnehmen möchten, können Sie sich aber gerne an unseren Kund*innenservice wenden.
zum Kundenservice